Seeing an AMH result marked low or high can make it feel as though one blood test has graded your fertility. It has not. An AMH blood test estimates ovarian reserve and is most useful for predicting how the ovaries may respond to fertility medicines. It does not count every egg, measure egg quality, diagnose infertility or tell you whether natural pregnancy will occur.

In Australia, an AMH result should be read against your age, the reporting laboratory’s assay and reference information, menstrual and medicine context, ultrasound findings and the reason for testing. There is no single numerical AMH chart that is safe for every person or laboratory.

A low result usually suggests a lower expected egg yield during stimulation. A high result can reflect more small follicles and a stronger response. Neither result is a verdict. The useful next step is to understand what decision the test can inform and what other information belongs beside it.

Quick answers about AMH levels

What does an AMH test tell you?

An AMH blood test estimates ovarian reserve and helps predict how the ovaries may respond to fertility medicines. It does not count every egg, measure egg quality or diagnose whether you can conceive naturally.

What is a normal AMH level for your age in Australia?

There is no universal normal number. AMH usually declines with age, but results vary widely between people and laboratory assays. Use the unit, age-related centile or range supplied by the laboratory that measured your sample.

What should you do after a low or high AMH result?

Confirm the unit and laboratory reference information, then review the result with a GP or fertility specialist alongside age, cycle history, medicines, ultrasound findings and reproductive goals before changing a treatment or pregnancy plan.

What does AMH measure, and when is the test useful?

Anti-Mullerian hormone, usually shortened to AMH, is produced by cells around small developing ovarian follicles. The amount detected in blood gives an indirect estimate of the follicle pool that may respond when the ovaries are stimulated.

This makes AMH useful before IVF or egg freezing, after some ovarian surgery or cancer treatment, and when ovarian reserve is one part of a broader fertility assessment. It can help a clinician anticipate a lower, expected or higher response and plan counselling or medicine doses accordingly.

AMH is not the hormone that triggers ovulation. Understanding how FSH, LH, oestrogen and progesterone change across the menstrual cycle helps separate ovarian reserve from the hormones involved in follicle growth, ovulation and the luteal phase.

AMH levels by age in Australia: how should you read the chart?

AMH generally declines with age, but people of the same age can have very different results. The safest comparison is the age-related centile or reference information supplied by the laboratory that measured your sample.

One South Australian study used the Elecsys assay in 654 women undergoing gynaecological assessment. Mean AMH peaked before age 25, was about half that peak by age 36 and about one quarter by age 40. The table below converts that finding into a relative index so the age pattern is easy to understand without inventing a universal pmol/L range.

A result that is higher than average for age does not reverse age-related changes in egg quality. A lower result in a younger person does not establish infertility. Both require the reason for testing and the wider clinical picture.

How accurate is an AMH test, and can the result be falsely low?

AMH is useful for estimating ovarian response, but it is not a perfectly fixed personal score. Different assays can produce non-identical values, and biological variation can occur even though AMH usually changes less across the cycle than FSH.

Prolonged hormonal contraception can suppress AMH or antral follicle count in some people. That does not mean contraception has permanently reduced ovarian reserve. Tell the clinician what you use, and do not stop contraception simply to make a result higher.

A clinician may consider a repeat baseline when the result is unexpected, a different assay was used, contraception may be affecting interpretation or a new treatment decision requires current information. Repeating the test without a clear decision can add cost and anxiety while leaving the same question unresolved.

What does low AMH mean if your periods are regular?

Low AMH usually predicts a lower number of follicles responding during ovarian stimulation. It does not mean that no eggs remain, ovulation has stopped or natural pregnancy is impossible.

You can have low AMH but regular periods because ovarian reserve and whether ovulation occurs in a particular cycle are related but different questions. Australian clinical guidance specifically notes that low AMH can occur in people with regular menstrual cycles and lower ovarian reserve.

Low AMH is also not the primary diagnostic test for premature ovarian insufficiency. That diagnosis requires the relevant menstrual history and hormone criteria. When pregnancy has not occurred, cycles have changed or treatment is being considered, a broader female fertility assessment can examine ovulation, reproductive anatomy and other factors AMH cannot evaluate.

Does high AMH mean PCOS or PMOS?

A higher AMH result can reflect a larger number of small follicles. During fertility treatment, it may predict a stronger or excessive response and help the clinic choose a safer individual stimulation plan.

High AMH can occur with polyendocrine metabolic ovarian syndrome, or PMOS, the name adopted by Australian professional bodies in 2026 for the condition previously called PCOS. It is not proof of PMOS. In adults, AMH may help define polycystic ovarian morphology only within the full diagnostic pathway.

Current guidance says AMH should not be used as a stand-alone PMOS test or for this purpose in adolescents. It also advises using either AMH or ultrasound to define ovarian morphology, rather than both, to limit overdiagnosis. The AMH and PCOS or PMOS assessment guide explains that boundary in detail.

When a high result appears with irregular cycles, acne or increased facial or body hair, the wider PMOS symptom pattern is more informative than the AMH number alone.

Does AMH predict natural pregnancy, egg quality or menopause?

AMH does not measure egg quality. Age is more informative for age-related changes in egg and embryo quality, while AMH mainly describes the quantity-related response expected from the ovaries.

Research on natural conception is not perfectly uniform. A 2017 prospective cohort of women aged 30 to 44 without known infertility found that diminished ovarian reserve biomarkers were not associated with reduced natural fertility during the study period. A 2024 cohort of 3,150 women reported a modest association between AMH below 1 ng/mL and a lower chance of conception.

Together, those findings support a cautious interpretation. AMH may carry some population-level information, but one result is a weak stand-alone forecast for an individual. Natural conception also depends on ovulation, sperm, fallopian tubes, timing and other health factors.

AMH also cannot predict the exact age at which you will reach menopause. Population trends are too broad for one result to provide a safe personal deadline for delaying pregnancy.

When the practical decision is when to have intercourse, focus on the fertile window and ovulation timing. Home ovulation tests detect a urinary LH rise; they do not measure AMH, ovarian reserve or egg quality.

How is AMH used for IVF and egg freezing?

AMH is more useful for estimating ovarian response and likely egg yield than for predicting the final chance of pregnancy or live birth. A lower result may mean fewer eggs are retrieved. A higher result may prompt a cautious protocol because excessive response can create treatment risk.

Very low AMH can support realistic counselling, but it should not be the sole reason to refuse IVF. Age, sperm, embryo development, uterine factors, treatment history and the planned protocol still influence the outcome.

Egg freezing decisions also involve age, reproductive goals, expected egg yield, cost, storage and the limits of future use. The wider fertility preservation options in Australia place AMH within that decision without turning it into a countdown clock.

How is an AMH blood test done in Australia?

AMH is measured from a blood sample. A GP or fertility specialist can decide whether the result is likely to change a clinical decision and provide a pathology referral when one is required.

Australian laboratories commonly report AMH in picomoles per litre, written as pmol/L. Some international reports use nanograms per millilitre, written as ng/mL. For unit conversion, 1 ng/mL is approximately 7.14 pmol/L. Converting the number does not make a reference range from another assay suitable for your report.

How much does an AMH test cost in Australia, and is Medicare available?

There is no single national AMH test price or universal Medicare outcome. Provider billing, referral requirements and the setting in which the test is ordered can produce different out-of-pocket amounts.

Current provider pages checked on 5 September 2026 illustrate the difference. 4Cyte states that patients with a valid Medicare referral have no out-of-pocket charge for AMH testing. IVFAustralia lists a $95 fee and states that its AMH service is not covered by Medicare.

These are provider-specific examples, not national price promises. Ask the referring clinician and pathology or fertility service for a current written quote, referral requirements and the likely amount you will pay before collection.

How can you interpret AMH test results in Australia?

The five-step decision map below is designed to keep the result attached to a real clinical question rather than turning it into a fertility score.

1. Confirm the unit and laboratory. Check whether the result is in pmol/L or ng/mL and use the reference information supplied with that assay.
2. Place the result beside age. Look for an age-related centile or category, while remembering that people of the same age still vary widely.
3. Identify why the test was ordered. An IVF-response question, an egg-freezing discussion and a general concern about future fertility require different interpretations.
4. Check the context. Note hormonal contraception, previous ovarian surgery or cancer treatment, cycle history and any ultrasound antral follicle count.
5. Ask what decision changes. The useful outcome may be a stimulation plan, another investigation, a referral or reassurance that AMH should not control the decision.

Worked example: low AMH with regular periods

A person with regular cycles receives an AMH result below the laboratory’s age-related range. The result may predict a lower egg yield if stimulation is planned, but the regular cycle pattern suggests ovulation may still be occurring. The next question is whether treatment timing, ultrasound or a wider fertility assessment would change the plan.

Worked example: an age-typical result while considering delay

A person receives a result within the laboratory’s expected range for age and is deciding whether to postpone pregnancy. The result is reassuring only about that ovarian reserve marker. It does not pause age-related changes in egg quality or provide a safe number of years to wait.

Worked example: high AMH with irregular cycles

A person has a higher-than-expected result, irregular periods and androgen-related symptoms. AMH can add ovarian morphology information in an adult assessment, but it does not complete a PMOS diagnosis. The cycle pattern and other diagnostic criteria determine what is investigated next.

What other fertility information belongs beside AMH?

Age and cycle history provide context for reproductive timing and ovulation. Antral follicle count uses ultrasound to show small visible follicles, while FSH and oestradiol may add cycle-specific endocrine information in selected assessments.

AMH cannot assess sperm, fallopian tubes or the uterus. A male fertility assessment may therefore be needed at the same time, and tubal or uterine investigations are chosen according to history and symptoms.

Frequently Asked Questions about AMH levels in Australia

What is a good AMH level to get pregnant?

There is no AMH threshold that guarantees natural pregnancy. A result can add ovarian reserve context, but age, ovulation, sperm, fallopian tubes, timing and other health factors still determine whether conception occurs.

Can low AMH be raised with supplements?

An AMH result can vary with the laboratory method, biological variation and hormonal contraception. A higher repeat number does not prove that ovarian reserve has been restored. Discuss supplements with a clinician rather than treating AMH as a target on its own.

Do I need to fast for an AMH blood test?

AMH usually does not require fasting. Follow the pathology request and collection instructions because another blood test ordered at the same time may require preparation.

Can an AMH test be done on any cycle day?

AMH can usually be measured on different cycle days because it varies less across the cycle than FSH. A clinician may still coordinate it with other blood tests or ultrasound.

Can an AMH test detect pregnancy?

No. AMH is an ovarian reserve marker. Pregnancy tests detect human chorionic gonadotrophin, or hCG, and answer a different question.

How long do AMH test results take in Australia?

Turnaround varies by pathology provider and location. One current Australian provider states that results are typically available within a week and sent to the referring doctor. Confirm timing with the service collecting your sample.

Next Steps in Australia

Start with the complete pathology report rather than the AMH number alone. Confirm the unit and laboratory, then arrange a GP or fertility-clinic review when the result is unexpected, treatment is being planned, cycles have changed or pregnancy timing is an important decision.

Healthdirect advises seeing a doctor after 12 months of trying when you are under 35 and after 6 months when you are over 35. Seek advice sooner when periods are irregular or absent, there is a known fertility concern, or waiting could materially affect treatment choices.

The Australian pathway for when to see a fertility specialist can help you prepare for referral. Take your cycle history, medicine list, ultrasound results and full pathology report, then ask which decision the AMH result changes.

Last reviewed: 5 September 2026
Next scheduled review: September 2027

References

Fertility2Family articles are researched using Australian Government health guidance, Australian professional publications, current provider information and peer-reviewed medical literature. The references below were used to research and medically recheck this article and provide further reading for readers who want to examine the evidence in more detail.

Royal Australian College of General Practitioners. Assessment of female fertility in the general practice setting
Australian general practice review explaining how AMH estimates ovarian reserve, predicts response to ovarian stimulation, can be tested across the cycle and requires age and full fertility context.

Royal Australian College of General Practitioners. Premature ovarian insufficiency and infertility
Australian clinical review stating that low AMH can occur with regular menstrual cycles, AMH is not recommended for diagnosing premature ovarian insufficiency and cannot diagnose menopause.

Australian and New Zealand Journal of Obstetrics and Gynaecology. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan
South Australian Elecsys-assay study of 654 women reporting that mean AMH peaked before age 25, halved by 36 and fell to one quarter of peak by 40.

American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion (2020)
Professional committee guidance distinguishing ovarian reserve from egg quality and explaining that AMH predicts ovarian response and egg yield more reliably than natural conception or live birth.

American Society for Reproductive Medicine. The use of hormonal contraceptives in fertility treatments: a committee opinion
Professional guidance describing suppression of AMH and antral follicle count during prolonged hormonal contraception and when a clinician-directed pause may provide a more accurate baseline.

American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome
Australian-led international recommendations limiting AMH to defined adult PMOS pathways, rejecting it as a stand-alone or adolescent test and requiring population and assay-specific cut-offs.

Royal Australian and New Zealand College of Obstetricians and Gynaecologists. RANZCOG Welcomes Polycystic Ovarian Syndrome (PCOS) Renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Australian professional announcement confirming the 2026 renaming of PCOS to PMOS and the transition to terminology reflecting the condition’s broader endocrine and metabolic features.

JAMA. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age
Prospective cohort of women aged 30 to 44 without known infertility, finding diminished ovarian reserve biomarkers were not associated with reduced natural fertility during the study period.

Fertility and Sterility. Antimüllerian hormone levels are associated with time to pregnancy in a cohort study of 3,150 women
Prospective cohort of 3,150 women reporting that AMH below 1 ng/mL was independently associated with a modest reduction in the chance of natural conception.

Healthdirect Australia. Infertility
Australian consumer guidance on infertility, common female and male factors, available assessments and when to seek medical advice after six or twelve months of trying.

4Cyte Pathology. AMH Testing
Current Australian provider information on AMH blood collection, referral access, typical result timing and its no out-of-pocket arrangement for patients with a valid Medicare referral.

4Cyte Pathology. Preparing for Your Testing
Current Australian pathology preparation guidance stating that fasting is not required unless a doctor specifically requests it and that individual collection instructions should take priority.

IVFAustralia. Anti Mullerian Hormone (AMH) Test & Ovarian Reserve
Current Australian fertility-clinic information listing a $95 AMH test and stating that this provider’s service is not covered by Medicare.

Te Whatu Ora – Health New Zealand. Anti-Mullerian Hormone
Laboratory test guidance providing the unit conversion used for report comparison: pmol/L equals ng/mL multiplied by 7.14, without replacing assay-specific reference information.